RecruitingNot ApplicableNCT07478263

Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes

Reducing Obesity and Risk for Type 2 Diabetes in Latinas Using a Novel Behavioral Strategy Addressing Appetitive Traits


Sponsor

University of California, San Diego

Enrollment

30 participants

Start Date

Mar 31, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Adapt the Regulation of Cues (ROC) treatment program for Latinas to see if it can treat prediabetes and prevent developing of Type 2 Diabetes and reduce weight.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Inclusion Criteria5

  • Women who self-identify as Hispanic/Latina, aged 18-55
  • BMI 30-45 kg/m2
  • Documented diagnosis of prediabetes also confirmed by HBA1c level of 5.7-6.4%
  • Spanish or English proficiency at a 5th grade level
  • Physician approval to participate

Exclusion Criteria7

  • Current diagnosis of T2D
  • Current Pregnancy or lactation or planning to get pregnant within the study duration
  • Recent history of heart disease, symptoms of angina, stroke, orthopedic problems that would limit activity during the following 6 months, or any other serious medical condition that would make physical activity unsafe
  • Currently enrolled in weight-loss program or taking medications for weight loss or prediabetes
  • Current moderate or severe alcohol or substance use disorder, acute suicidal ideation, psychosis, compensatory behaviors, or a diagnosis of bulimia
  • Hospitalization due to a psychiatric disorder in the past year.
  • Planning to move from the San Diego area within the next 6 months

Interventions

BEHAVIORALRegulation of Cues

ROC includes appetite awareness training and cue-exposure treatment adapted particularly for Latinas with prediabetes.


Locations(1)

UCSD Center for Healthy Eating and Activity Research (CHEAR

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07478263


Related Trials